CCL Healthcare

Secondary Printed Packaging for Pharmaceuticals

CCL Industries Announces Q2 Results

CCL Healthcare

CCL's Q2 highlights include:

  • Adjusted basic earnings per Class B share of $0.68, up 21.4% earnings per Class B share of $0.63 up 50.0%; currency translation impact nominal
  • Sales increased 30.5% supported by 5.7% organic sales growth at CCL and strong first full quarter for CCL Secure
  • Checkpoint continued to deliver solid operating results, 11.4% operating margin
  • Completed five for one stock split on 5 June, 2017

CCL's six-month highlights include:

  • Year-to-date adjusted basic earnings per Class B share of £1.25, up 14.7%; basic earnings per Class B share of $1.13, up 21.5%
  • Sales increased 26.7% supported by 6.2% CCL organic sales growth
  • Operating income increased 18.5% driven by strong performance at the CCL Segment augmented by acquisitions

For more information, please download this free white paper.

 

 

 

Available Downloads